TY - JOUR
T1 - Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: A prospective study
AU - Foster, L W
AU - McLellan, L.
AU - Rybicki, L.
AU - Dabney, J.
AU - Copelan, E.
AU - Bolwell, Brian
PY - 2013/5/1
Y1 - 2013/5/1
N2 - This prospective study validates the finding from retrospective research that having an inpatient lay care-partner (CP) is associated with better survival following allogeneic BMT. Compared with patients without a CP (n=76), patients with a CP (n=88) have significantly better OS (P=0.017) and relapse-free survival (RFS) (P=0.020). Four-year and median survivals were 42% and 36 months among patients with CPs, compared with 26% and 10 months among those without CPs. Four-year survival and median RFS were 39% and 25 months among those with CPs, compared with 23% and 7 months among those without CPs. Further, better survival and RFS were associated with CP visit duration of >3 h per day (P=0.005 and P=0.007, respectively) and with CP frequency of visits >75% of inpatient days (P=0.004 and P=0.010, respectively). A CP support program should encourage not only presence of a CP but also duration and frequency of CP visits associated with better patient survival. © 2013 Macmillan Publishers Limited All rights reserved.
AB - This prospective study validates the finding from retrospective research that having an inpatient lay care-partner (CP) is associated with better survival following allogeneic BMT. Compared with patients without a CP (n=76), patients with a CP (n=88) have significantly better OS (P=0.017) and relapse-free survival (RFS) (P=0.020). Four-year and median survivals were 42% and 36 months among patients with CPs, compared with 26% and 10 months among those without CPs. Four-year survival and median RFS were 39% and 25 months among those with CPs, compared with 23% and 7 months among those without CPs. Further, better survival and RFS were associated with CP visit duration of >3 h per day (P=0.005 and P=0.007, respectively) and with CP frequency of visits >75% of inpatient days (P=0.004 and P=0.010, respectively). A CP support program should encourage not only presence of a CP but also duration and frequency of CP visits associated with better patient survival. © 2013 Macmillan Publishers Limited All rights reserved.
KW - allogeneic BMT
KW - lay care-partner support
KW - patient survival
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877656487&origin=inward
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84877656487&origin=inward
U2 - 10.1038/bmt.2012.208
DO - 10.1038/bmt.2012.208
M3 - Article
C2 - 23103681
SN - 0268-3369
VL - 48
SP - 671
EP - 677
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 5
ER -